Australia

Universal Robots announces seamless integration with Siemens PLCs

Company accelerates its commitment to "Automation for Anyone, Anywhere" by supporting the automation requirements of global companies. ODENSE, Denmark, April 18, 2024 /PRNewswire/ -- Universal Robots (UR), the world's leading collaborative robot (cobot) company, has now integrated the Standard Ro...

2024-04-19 02:10 557

CIIE invites Namibian businesses to seize opportunities in China

SHANGHAI, April 16, 2024 /PRNewswire/ -- A promotional event for the seventh China International Import Expo and the Hongqiao International Economic Forum was held inWindhoek, capital of Namibia, on April 9. Rep...

2024-04-17 16:39 917

Infosys drives hybrid cloud-powered innovation for Team Global Express

Infosys Cobalt accelerates the customer's transition to the new environment, enabling them to deliver exceptional customer service SYDNEY, April 16, 2024 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services a...

2024-04-16 12:59 770

DAZU Rock Carvings: Art Treasure Carved into Endless Time

CHONGQING, China, April 15, 2024 /PRNewswire/ -- DAZU Rock Carvings have witnessed thousands of years. From the foundation of the early Tang Dynasty, the refining in the last five dynasties of the Tang Dynasty, to the glory of the North Song Dynasty and the South Song Dynasty, and then to the aft...

2024-04-16 00:30 912

Protiviti Transforms Cyber Risk Consulting with CYFIRMA's Advanced Intelligence-Led Cybersecurity

CYFIRMA's Real-time Intelligence Will be Harnessed to Mitigate Emerging Cyber Risks and Support Client Business Growth HONG KONG, SINGAPORE and SYDNEY, April 15, 2024 /PRNewswire/ -- Today, Protiviti, a global consulting firm renowned for delivering expert insights and tailored solutions, and CY...

2024-04-15 21:00 940

First patient treated in Actinogen's XanaMIA phase 2b Alzheimer's disease trial

Plus, Actinogen receives approval of its application for a UK Innovation Passport as part of the Innovative Licensing and Access Pathway (ILAP) for Xanamem in the treatment of Alzheimer's disease Enrolment in XanaCIDD phase 2a trial of cognitive impairment and depression has surpassed 90% SYDNE...

2024-04-15 20:30 891

Getac Commissioned Survey Highlights Rugged Technology's Role In Transforming Industrial Operations

IRVINE, Calif., April 10, 2024 /PRNewswire/ -- Getac Technology Corporation , a leading producer of rugged technology, announced findings from the Getac-sponsored IDC InfoBrief titled, "Redefining Total Cost of Ownership: Rugged Technologies to Empower Industrial Operati...

2024-04-10 23:00 1516

AirCar developer signs groundbreaking manufacturing deal

KleinVision a.s., the Slovakia-based developer of the world's first certified flying car, the AirCar, has made a groundbreaking move towards realizing the dreams of individuals seeking to navigate through traffic congestion by taking to the skies in their cars NITRA, Slovakia, March 27, 2024 /PR...

2024-03-27 15:00 1272

White Cliff (ASX:WCN) unfurls historic high-grade uranium-copper from Northwest Territories

PERTH, Australia, March 26, 2024 /PRNewswire/ -- White Cliff Minerals dataset digitisation efforts have unearthed multiple high-grade uranium and copper targets in the northern half of its large-scale Radium Point exploration project inCanada's Northwest Territories. The older historical dataset...

2024-03-26 16:30 826

Compute for Climate Fellowship Announces Inaugural Winners and Opens Applications for 2024

The program funds proof of concepts for new ideas leveraging advanced cloud computing, including generative AI and high-performance computing, to solve some of the biggest challenges in the fight against climate change LJUBLJANA, Slovenia, March 21, 2024 /PRNewswire/ -- The International Researc...

2024-03-21 20:00 1443

Enfinity Global completes a minority sale of its 400 MW operating portfolio in the United States to Kyushu Electric

MIAMI, March 19, 2024 /PRNewswire/ -- Enfinity Global Inc., a leader in renewable energy, today announced the successful completion of a minority sale in its 400 MW U.S. operating portfolio to Kyushu Electric Power Co. Inc. (Kyushu Electric), a leading Japanese utility. Kyushu Electric has now a ...

2024-03-19 14:30 1243

REC Wins Best Solar Panels and Best After-Sales Support in 2024 for the 2nd Year in a Row

MELBOURNE, Australia, March 15, 2024 /PRNewswire/ -- REC Group , an international pioneering solar energy company, is delighted to announce that it has been awarded "Best Sola...

2024-03-15 07:00 1665

Pulsenmore is expanding the application of its home ultrasound solution for pregnant women: a clinical trial with Michigan Medicine will focus on the remote assessment of the fetal biophysical profile

RAMAT GAN, Israel, March 13, 2024 /PRNewswire/ -- Pulsenmore (TASE:PULS), the world leader in self-scan ultrasound technology for at-home use and remote clinical diagnosis, announces its new clinical study collaboration with Michigan Medicine. The study will examine the ability to conduct a remot...

2024-03-14 06:00 2671

Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range

Highlights * Clarity recently reported that in its diagnostic Phase 1/2 trial, COBRA, 64 Cu-SAR-bisPSMA was found to be safe and highly effective in detecting prostate cancer (PC) lesions in patients with biochemical recurrence (BCR). * In trial participants where standard of care (SOC) imagin...

2024-03-08 22:02 1635

PharmAust announces positive Phase 1 MEND Study Top-Line Results in MND / ALS

Highlights: * Monepantel displays a superior safety, tolerability to the leading FDA approved drug Relyvrio® * Preliminary efficacy data shows a 58% reduction in the rate of disease progression for Cohort 2 (High Dose) using the FDA primary efficacy endpoint, ALSFRS-R * Confirmation that m...

2024-02-28 20:47 1299

NIGO DESIGNS FIRST PENFOLDS GRANGE LIMITED-EDITION

An icon re-imagined. First-ever design takeover by cultural pioneer and Human Made Creative Director. ADELAIDE, Australia, Feb. 23, 2024 /PRNewswire/ -- Today Penfolds unveiled a new collaboration for Penfolds flagship wine, Grange. TheGrange by NIGO release celebrates the first-ever design take...

2024-02-23 15:07 1145

The Kingdom of Saudi Arabia unveils Zarqa Al Yamama - the inaugural Arabic Grand Opera

LONDON, Feb. 21, 2024 /PRNewswire/ -- Zarqa Al Yamama, the first Grand Opera produced by The Saudi Theater and Performing Arts Commission, one of the 11 sector specific commissions under the Ministry of Culture, was internationally unveiled at an exclusive event inLondon's historic Goldsmiths' Ha...

2024-02-21 21:40 1489

Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World

* Glenmark will be responsible for further developing, registering, and commercializing Envafolimab inIndia, Asia Pacific, Middle East and Africa, Russia, CIS, and Latin America. * Jiangsu Alphamab and 3D Medicines will receive a low double digit Million US Dollar amount up to launch, additio...

2024-01-25 18:00 1563

Positive Xanamem® human PET study published in the Journal of Alzheimer's Disease demonstrating robust CNS[1] target enzyme occupancy

The study confirms that Xanamem is a brain-penetrant inhibitor of the tissue cortisol synthesis enzyme, 11β-HSD1, with high levels of target occupancy at doses as low as 5 mg SYDNEY, Jan. 24, 2024 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) announces that its human Positron Emission Tom...

2024-01-24 21:30 1314

FDA CLEARANCE OF AMPLIA'S IND FOR PANCREATIC CANCER TRIAL IN US

HIGHLIGHTS * The US FDA has cleared Amplia's Investigational New Drug (IND) Application for a clinical trial of narmafotinib in theUSA * The proposed trial would explore the combination of narmafotinib and FOLFIRINOX in advanced pancreatic cancer patients in theUSA MELBOURNE, Australia ,Jan. ...

2024-01-18 10:31 1141
12345 ... 62